Document is current
Any future updates will be listed below
-
Authors
Regnault, Antoine https://orcid.org/0000-0001-8234-2896
Prato, Maria Key https://orcid.org/0000-0003-4421-1160
Quéré, Stéphane https://orcid.org/0000-0001-8832-6053
Benoit, Anne
Massat, Nathalie J. https://orcid.org/0000-0002-1095-994X
Morel, Thomas https://orcid.org/0000-0002-0690-5359
-
Funding
Funding for this research was provided by:
The study was funded by UCB
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 22 June 2025
First Online: 17 October 2025
Change Date: 21 November 2025
Change Type: Update
Change Details: In this article, the formatting of table 1 was incorrect. The article has been updated.
Competing interests
: A.B., N.J.M., T.M., and M.K.P. are employees of UCB, and may hold/have access to stock/share options. M.K.P. holds/has access to GSK stocks/share options. A.R. and S.Q. are employees of Modus Outcomes. A.B. is a recipient of the GSK Vaccine grant for PhD studies.
